» Articles » PMID: 34824211

Aberrant Integration of Hepatitis B Virus DNA Promotes Major Restructuring of Human Hepatocellular Carcinoma Genome Architecture

Abstract

Most cancers are characterized by the somatic acquisition of genomic rearrangements during tumour evolution that eventually drive the oncogenesis. Here, using multiplatform sequencing technologies, we identify and characterize a remarkable mutational mechanism in human hepatocellular carcinoma caused by Hepatitis B virus, by which DNA molecules from the virus are inserted into the tumour genome causing dramatic changes in its configuration, including non-homologous chromosomal fusions, dicentric chromosomes and megabase-size telomeric deletions. This aberrant mutational mechanism, present in at least 8% of all HCC tumours, can provide the driver rearrangements that a cancer clone requires to survive and grow, including loss of relevant tumour suppressor genes. Most of these events are clonal and occur early during liver cancer evolution. Real-time timing estimation reveals some HBV-mediated rearrangements occur as early as two decades before cancer diagnosis. Overall, these data underscore the importance of characterising liver cancer genomes for patterns of HBV integration.

Citing Articles

Viral Oncogenesis: Synergistic Role of Genome Integration and Persistence.

La Frazia S, Pauciullo S, Zulian V, Garbuglia A Viruses. 2025; 16(12.

PMID: 39772271 PMC: 11728759. DOI: 10.3390/v16121965.


HBV-Induced Carcinogenesis: Mechanisms, Correlation With Viral Suppression, and Implications for Treatment.

Tu T, McQuaid T, Jacobson I Liver Int. 2024; 45(1):e16202.

PMID: 39720865 PMC: 11669079. DOI: 10.1111/liv.16202.


The role of the hepatitis B virus genome and its integration in the hepatocellular carcinoma.

Li W, Wang S, Jin Y, Mu X, Guo Z, Qiao S Front Microbiol. 2024; 15:1469016.

PMID: 39309526 PMC: 11412822. DOI: 10.3389/fmicb.2024.1469016.


The Spiral Model of Evolution: Stable Life Forms of Organisms and Unstable Life Forms of Cancers.

Kasperski A, Heng H Int J Mol Sci. 2024; 25(17).

PMID: 39273111 PMC: 11395208. DOI: 10.3390/ijms25179163.


The impact of integrated hepatitis B virus DNA on oncogenesis and antiviral therapy.

Zhang M, Chen H, Liu H, Tang H Biomark Res. 2024; 12(1):84.

PMID: 39148134 PMC: 11328401. DOI: 10.1186/s40364-024-00611-y.


References
1.
Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

2.
Midorikawa Y, Yamamoto S, Ishikawa S, Kamimura N, Igarashi H, Sugimura H . Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays. Oncogene. 2006; 25(40):5581-90. DOI: 10.1038/sj.onc.1209537. View

3.
Wong N, Lai P, Pang E, Leung T, Lau J, Johnson P . A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping. Hepatology. 2000; 32(5):1060-8. DOI: 10.1053/jhep.2000.19349. View

4.
Meyer M, Wiedorn K, Hofschneider P, Koshy R, Caselmann W . A chromosome 17:7 translocation is associated with a hepatitis B virus DNA integration in human hepatocellular carcinoma DNA. Hepatology. 1992; 15(4):665-71. DOI: 10.1002/hep.1840150419. View

5.
Meng G, Tan Y, Fan Y, Wang Y, Yang G, Fanning G . TSD: A Computational Tool To Study the Complex Structural Variants Using PacBio Targeted Sequencing Data. G3 (Bethesda). 2019; 9(5):1371-1376. PMC: 6505135. DOI: 10.1534/g3.118.200900. View